retatrutide drug retatrutide clinical trial A new clinical trial from Eli Lilly and Company suggests its Unapproved weight-loss drug "reta" sold

Araj-Khodaei M, Ayati MH, Azizi Zeinalhajlou A, Novinbahador T, Yousefi M, Shiri M, Mahmoodpoor A, Shamekh A, Namazi N, Sanaie S

Further supporting these findings, a 2024 study by Kuryata and Frolova investigated the efficacy of 2 grams per day of L-carnitine in post-COVID patients dealing with long-term systemic complications

Liu J et al

Novo Nordisk-CAS Research Fund grant NNCAS-20171-CC (DY) and SA-SIBS Scholarship Program (DY)

As care becomes more integrated across gastroenterology, endocrinology and obesity medicine, these agents may help reduce steroid exposure and improve overall disease stability when used alongside standard Crohns therapies. An unexplored area Approximately half of patients with Crohns disease in the United States have obesity, according to study background

Prunes or prune juice provide both fiber and sorbitol, which has a mild laxative effect